XOMA ROYALTY Trademark

Trademark Overview

On Thursday, March 28, 2024, a trademark application was filed for XOMA ROYALTY with the United States Patent and Trademark Office. The USPTO has given the XOMA ROYALTY trademark a serial number of 98473912. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 6, 2026. This trademark is owned by XOMA (US) LLC. The XOMA ROYALTY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research and development

General Information

Serial Number98473912
Word MarkXOMA ROYALTY
Filing DateThursday, March 28, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2025

Trademark Statements

Goods and Servicespharmaceutical research and development
NOT AVAILABLE"ROYALTY"

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXOMA (US) LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 64908
US
Party NameXOMA (US) LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 64908
US

Trademark Events

Event DateEvent Description
Friday, March 29, 2024NEW APPLICATION ENTERED
Friday, August 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Thursday, October 17, 2024NON-FINAL ACTION WRITTEN
Thursday, October 17, 2024NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, January 16, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 8, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 8, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 8, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 7, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 13, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 13, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 6, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, January 6, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, May 14, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 6, 2026TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 6, 2026DIVISIONAL REQUEST RECEIVED
Monday, July 6, 2026DIVISIONAL PROCESSING COMPLETE
Monday, January 5, 2026SOU EXTENSION 1 FILED
Monday, July 6, 2026SOU EXTENSION 1 GRANTED
Monday, July 6, 2026CORRECTED NOA E-MAILED
Monday, July 6, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 8, 2026SOU TEAS EXTENSION RECEIVED

Related Keywords

royalty xoma development research pharmaceutical